Clostridium bacilli Not Specified

Information

Microbe Identification

Clostridium bacilli Not Specified

Microbe id: PMDBM2010193
Level: species
NCBI Taxonomy ID: n.a.
Taxonomy Species: Clostridium bacilli [n.a.]
Taxonomy Genus: Clostridium [1485]
Taxonomy Family: Clostridiaceae [31979]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Clostridium bacilli Not Specified

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Clostridium bacilli Not Specified


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Clostridium bacilli Not Specified distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Clostridium bacilli Not Specified in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Clostridium bacilli Not Specified

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA449784🔗-4.06365602317543mNGS
Kidney Failure, Chronic PRJNA648014🔗3.4225627599742716S
Hemangioma, Cavernous PRJNA629755🔗-4.25440543490626mNGS
Depression, Postpartum PRJNA637228🔗3.6029758483114616S
Diabetes Mellitus, Type 2 PRJNA646010🔗-4.3734656906471216S
Diarrhea PRJEB14038🔗-4.25446804570273mNGS
Diarrhea PRJNA317326🔗4.4919608859061116S
Dwarfism PRJNA808649🔗-3.53138275176149mNGS
Colorectal Neoplasms PRJNA936589🔗-4.79251774841477mNGS
Colorectal Neoplasms PRJNA1138893🔗-4.28141635430558mNGS
Colorectal Neoplasms PRJNA763023🔗-3.77180067724428mNGS
Colorectal Neoplasms PRJNA1167935🔗-3.64432330680182mNGS
Colorectal Neoplasms PRJNA284542🔗3.7975061250678116S
Lupus Erythematosus, Systemic PRJEB52971🔗-3.890043659770716S
Tuberculosis PRJNA795263🔗-4.3320237054894416S
Parkinson Disease PRJNA762484🔗-3.52062069365181mNGS
Colitis, Ulcerative PRJNA993675🔗-3.84278929507173mNGS
Colitis, Ulcerative PRJEB42155🔗-3.74141196322244mNGS
Colitis, Ulcerative PRJNA398089🔗3.20504404738549mNGS
Campylobacter Infections PRJNA660443🔗3.83310167624295mNGS
Spinal Cord Injuries PRJNA861246🔗-4.3213913470868616S
Hepatitis B, Chronic PRJNA872871🔗3.2080707105856216S
Osteoporosis, Postmenopausal PRJNA946183🔗4.15022596683563mNGS
Carcinoma, Renal Cell PRJNA842560🔗3.9585682523728116S
Metabolic Syndrome PRJNA417579🔗4.1615152517375216S
Esophagitis PRJNA656138🔗4.6547664186174416S
Hepatolenticular Degeneration PRJNA1038771🔗4.0397446564591116S
Feeding and Eating Disorders PRJEB55035🔗-3.6133985491531716S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.163839840149216S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗-4.158031256104716S
Asthma PRJNA950484🔗-3.9230320798375116S
Leukemia, Myeloid, Acute PRJNA813705🔗-3.65910084330093mNGS
Crohn Disease PRJNA938107🔗-4.1105030321769916S
Crohn Disease PRJNA793776🔗-4.09885975600568mNGS
Crohn Disease PRJEB76677🔗-4.08977093517764mNGS
Crohn Disease PRJNA813736🔗-3.73294247256639mNGS
Crohn Disease PRJNA993675🔗-3.57674743107821mNGS
Crohn Disease PRJEB42155🔗3.91419630462394mNGS
Crohn Disease PRJNA1156939🔗4.3097200857144216S
Psoriasis PRJNA938297🔗-3.96637932495681mNGS
Mastitis PRJNA667141🔗-4.254906728938816S
Polycystic Ovary Syndrome PRJNA530971🔗4.36518943960657mNGS
Moyamoya Disease PRJNA917033🔗-4.0548103708407216S
Meningioma PRJNA626591🔗-4.1525778358154616S
Appendicitis PRJDB8606🔗-3.6979600192811216S
Diabetic Retinopathy PRJNA646010🔗-4.358805945807216S
Dermatitis, Atopic PRJEB45443🔗3.72482586450452mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗-3.65689309716826mNGS
Cholangiocarcinoma PRJNA932948🔗-3.80500866335255mNGS
Anorexia Nervosa PRJEB11199🔗3.310224584674916S
Neuroblastoma PRJEB63351🔗-3.40827403734501mNGS
Myasthenia Gravis PRJEB41297🔗-4.0848528223141116S
IgA Deficiency PRJNA967340🔗-3.7108505571834916S
Depressive Disorder, Major PRJNA762199🔗-3.84213957630214mNGS
Depressive Disorder, Major PRJNA943232🔗-3.67667649245208mNGS
Schistosomiasis japonica PRJNA625383🔗3.9410383845210916S
Cholelithiasis PRJNA999028🔗-4.39504177850565mNGS
Alzheimer Disease PRJEB51982🔗-4.1401062583168416S
Liver Cirrhosis PRJNA861246🔗-4.3491063341396316S
Diabetes Mellitus PRJNA400325🔗-4.5517293875136516S
Diabetes Mellitus PRJNA774037🔗-3.5262288074040416S
HIV Infections PRJNA810567🔗4.0471564288490916S
Inflammatory Bowel Diseases PRJNA511372🔗-3.2584845261745mNGS
Biliary Atresia PRJNA730640🔗-3.94171729654733mNGS
Renal Insufficiency, Chronic PRJNA562327🔗3.7378607694377516S
Renal Insufficiency, Chronic PRJNA949558🔗3.9861109633683416S
Breast Neoplasms PRJNA383849🔗-3.355027800359916S
Breast Neoplasms PRJNA658160🔗-3.1518704746718116S
COVID-19 PRJNA624223🔗-3.95666240138996mNGS
COVID-19 PRJNA769052🔗-3.9026970124695516S
Sepsis PRJNA641414🔗3.8356084568147816S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Clostridium bacilli Not Specified



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Clostridium bacilli Not Specified



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Clostridium bacilli Not Specified

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Clostridium bacilli Not Specified


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Clostridium bacilli Not Specified



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Clostridium bacilli Not Specified

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Clostridium bacilli Not Specified

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Clostridium bacilli Not Specified

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Clostridium bacilli Not Specified



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Clostridium bacilli Not Specified


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Clostridium bacilli Not Specified


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?